Citation: Xie Jianhua, Lu Yao, Yu Baiqing, Wu Jun, Liu Jie. Galactose-modified enzymatic synthesis of poly(amino-co-ester) micelles for co-delivery miR122 and sorafenib to inhibit hepatocellular carcinoma development[J]. Chinese Chemical Letters, ;2020, 31(5): 1173-1177. doi: 10.1016/j.cclet.2019.10.030 shu

Galactose-modified enzymatic synthesis of poly(amino-co-ester) micelles for co-delivery miR122 and sorafenib to inhibit hepatocellular carcinoma development

Xie Jianhua ¹ ,
Lu Yao ¹ ,
Yu Baiqing ,
Wu Jun ^*, ,
Liu Jie ^*,

School of Biomedical Engineering, Sun Yat-sen University, Guangzhou 510006, China

wujun29@mail.sysu.edu.cn

liujie56@mail.sysu.edu.cn

Received Date: 25 September 2019
Revised Date: 22 October 2019
Accepted Date: 24 October 2019
Available Online: 30 October 2019

Figures(6)

Nanomaterials as drug carriers hold promise for the treatment of carcinomas, but integrating multiple functions into a single vector is difficult. In this study, we aim to develop efficient materials as vectors for co-delivery of microRNA-122 (miR-122) and sorafenib (SRF). We successfully synthesized amphiphilic galactose-modified PEGylated poly(amino-co-ester) (Gal-PEG-PPMS) copolymers consisted of hydrophilic Gal-PEG5k chain segments and hydrophobic poly(ω-pentadecalactone-co-N-methyldiethyleneamine-co-sebacic acid) chain segments, which self-assembled to form cationic micelles at pH 5.2. The results showed that the micelles could encapsulate SRF and bind miR122 simultaneously, increase cellular uptake efficiency. Furthermore, the micelles showed favorable transfection efficiency in enhancing miR122 expression level, the migration and invasion ability of hepatocellular carcinoma (HCC) cells were significantly inhibited after being transfected with miR122-loaded micelles. Most importantly, the co-delivery micelles decreased cell activities of HepG2 cells, which was more effective than miR122 or SRF loaded micelles alone. Collectively, Gal-PEG-PPMS nanoparticles are promising multifunctional carriers for miR122 and SRF co-delivery system to treat HCC.
- Micelles,
- miR122,
- Sorafenib,
- Hepatocellular carcinoma,
- Co-delivery
1. [1]
  F. Bray, J. Ferlay, I. Soerjomataram, et al., CA Cancer J. Clin. 68(2018) 394-424. doi: 10.3322/caac.21492
2. [2]
  D. Lee, I.M.J. Xu, D.K.C. Chiu, et al., J. Clin. Invest. 127(2017) 1856-1872. doi: 10.1172/JCI90253
3. [3]
  R. Rudalska, D. Dauch, T. Longerich, et al., Nat. Med. 20(2014) 1138-1146. doi: 10.1038/nm.3679
4. [4]
  F. Feng, Q. Jiang, S. Cao, et al., Biochim. Biophys. Acta-Gen. Subj. 1862(2018) 1017-1030. doi: 10.1016/j.bbagen.2018.01.011
5. [5]
  S.H. Hsu, B. Wang, J. Kota, et al., J. Clin. Invest. 122(2012) 2871-2883. doi: 10.1172/JCI63539
6. [6]
  G. Lou, X. Song, F. Yang, et al., J. Hematol. Oncol. 8(2015) 122. doi: 10.1186/s13045-015-0220-7
7. [7]
  Y. Xu, J. Huang, L. Ma, et al., Cancer Lett. 371(2016) 171-181. doi: 10.1016/j.canlet.2015.11.034
8. [8]
  D. Rosenblum, N. Joshi, W. Tao, J.M. Karp, D. Peer, Nat. Commun. 9(2018) 1410. doi: 10.1038/s41467-018-03705-y
9. [9]
  N. Kamaly, J.C. He, D.A. Ausiello, O.C. Farokhzad, Nat. Rev. Nephrol.12(2016) 738-753. doi: 10.1038/nrneph.2016.156
10. [10]
  S. Wilhelm, A.J. Tavares, Q. Dai, et al., Nat. Rev. Mater. 1(2016) 16014. doi: 10.1038/natrevmats.2016.14
11. [11]
  D.B. Kirpotin, D.C. Drummond, Y. Shao, et al., Cancer Res. 66(2006) 6732-6740. doi: 10.1158/0008-5472.CAN-05-4199
12. [12]
  S. Schottler, G. Becker, S. Winzen, et al., Nat. Nanotechnol. 11(2016) 372-377. doi: 10.1038/nnano.2015.330
13. [13]
  P.Y. Teo, W. Cheng, J.L. Hedrick, Y.Y. Yang, Adv. Drug Deliv. Rev. 98(2016) 41-63. doi: 10.1016/j.addr.2015.10.014
14. [14]
  A. Corma, S. Iborra, A. Velty, Chem. Rev. 107(2007) 2411-2502. doi: 10.1021/cr050989d
15. [15]
  Z.Z. Jiang, Biomacromolecules 11(2010) 1089-1093. doi: 10.1021/bm1000586
16. [16]
  Z. Ye, W.R. Wu, Y.F. Qin, et al., Adv. Funct. Mater. 28(2018)1706600. doi: 10.1002/adfm.201706600
17. [17]
  M.P. Leal, C. Caro, M.L. Garcia-Martin, Nanoscale 9(2017) 8176-8184. doi: 10.1039/C7NR01607G
18. [18]
  X.F. Zhang, B. Liu, Z. Yang, et al., Colloids Surfaces B 115(2014) 349-358. doi: 10.1016/j.colsurfb.2013.12.029
19. [19]
  J.A. Kemp, M.S. Shim, C.Y. Heo, Y.J. Kwon, Adv. Drug Deliv. Rev. 98(2016) 3-18. doi: 10.1016/j.addr.2015.10.019
1. [1]
  Yunjie Dang , Yanru Feng , Xiao Chen , Chaoxing He , Shujie Wei , Dingyang Liu , Jinlong Qi , Huaxing Zhang , Shaokun Yang , Zhiyun Niu , Bai Xiang . Development of a multi-level pH-responsive lipid nanoplatform for efficient co-delivery of siRNA and small-molecule drugs in tumor treatment. Chinese Chemical Letters, 2024, 35(12): 109660-. doi: 10.1016/j.cclet.2024.109660
2. [2]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
3. [3]
  Jun Xiong , Ke-Ke Chen , Neng-Bin Xie , Wei Chen , Wen-Xuan Shao , Tong-Tong Ji , Si-Yu Yu , Yu-Qi Feng , Bi-Feng Yuan . Demethylase-assisted site-specific detection of N¹-methyladenosine in RNA. Chinese Chemical Letters, 2024, 35(5): 108953-. doi: 10.1016/j.cclet.2023.108953
4. [4]
  Jinyu Guo , Yandai Lin , Shaohua He , Yueqing Chen , Fenglu Li , Renjie Ruan , Gaoxing Pan , Hexin Nan , Jibin Song , Jin Zhang . Utilizing dual-responsive iridium(Ⅲ) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy. Chinese Chemical Letters, 2024, 35(9): 109537-. doi: 10.1016/j.cclet.2024.109537
5. [5]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
6. [6]
  Tong Zhang , Chao Sun , Shubin Yang , Zimin Cai , Sifeng Zhu , Wendian Liu , Yun Luan , Cheng Wang . Inhalation of taraxasterol loaded mixed micelles for the treatment of idiopathic pulmonary fibrosis. Chinese Chemical Letters, 2024, 35(8): 109248-. doi: 10.1016/j.cclet.2023.109248
7. [7]
  Mengjuan Sun , Muye Zhou , Yifang Xiao , Hailei Tang , Jinhua Chen , Ruitao Zhang , Chunjiayu Li , Qi Ya , Qian Chen , Jiasheng Tu , Qiyue Wang , Chunmeng Sun . Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109110-. doi: 10.1016/j.cclet.2023.109110
8. [8]
  Yihan Zhou , Duo Gao , Yaying Wang , Li Liang , Qingyu Zhang , Wenwen Han , Jie Wang , Chunliu Zhu , Xinxin Zhang , Yong Gan . Worm-like micelles facilitate the intestinal mucus diffusion and drug accumulation for enhancing colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108967-. doi: 10.1016/j.cclet.2023.108967
9. [9]
  Yu Qin , Mingyang Huang , Chenlu Huang , Hannah L. Perry , Linhua Zhang , Dunwan Zhu . O₂-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma. Chinese Chemical Letters, 2024, 35(7): 109171-. doi: 10.1016/j.cclet.2023.109171
10. [10]
  Yuanyuan Zeng , Fang Liu , Jun Wang , Bianfei Shao , Tao He , Zhongzheng Xiang , Yan Wang , Shunyao Zhu , Tian Yang , Siting Yu , Changyang Gong , Lei Liu . Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chinese Chemical Letters, 2025, 36(2): 109734-. doi: 10.1016/j.cclet.2024.109734
11. [11]
  Ke Gong , Jinghan Liao , Jiangtao Lin , Quan Wang , Zhihua Wu , Liting Wang , Jiali Zhang , Yi Dong , Yourong Duan , Jianhua Chen . Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters, 2024, 35(5): 108888-. doi: 10.1016/j.cclet.2023.108888
12. [12]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
13. [13]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
14. [14]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
15. [15]
  Qin Yu , Haisheng He , Jianping Qi , Yi Lu , Wei Wu . Oral delivery of insulin by barbed microneedles actuated by intestinal peristalsis. Chinese Chemical Letters, 2024, 35(9): 109888-. doi: 10.1016/j.cclet.2024.109888
16. [16]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
17. [17]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
18. [18]
  Weiyu Chen , Zenghui Li , Chenguang Zhao , Lisha Zha , Junfeng Shi , Dan Yuan . Enzyme-modulate conformational changes in amphiphile peptide for selectively cell delivery. Chinese Chemical Letters, 2024, 35(12): 109628-. doi: 10.1016/j.cclet.2024.109628
19. [19]
  Wen Xiao , Fazhan Wang , Yangzhuo Gu , Xi He , Na Fan , Qian Zheng , Shugang Qin , Zhongshan He , Yuquan Wei , Xiangrong Song . PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines. Chinese Chemical Letters, 2024, 35(5): 108755-. doi: 10.1016/j.cclet.2023.108755
20. [20]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(737)
HTML views(49)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142